Alterations in pyramidal neurons from the sensorimotor cortex may be responsible for some of the cognitive and motor symptoms of Huntington's disease (HD). The present experiments used R6/2 transgenic mice which express exon 1 of the human HD gene with an expanded number of CAG repeats. We characterized alpha- 2
Introduction
Huntington's disease (HD) is a neurodegenerative disorder that includes motor and cognitive deficits (Josiassen et al. 1983; Thompson et al. 1988 ). An abnormal expansion of CAG repeats on the huntingtin (htt) gene is responsible for the disease (Nasir et al. 1996; Schilling et al. 1995; Snell et al. 1993) . In human, mutated htt induces a preferential loss of medium-sized spiny neurons (MSSNs) of the striatum, and to a lesser extent, a loss of cortical neurons as the disease progresses (Albin et al. 1992; DiFiglia 1990; Graveland et al. 1985; Heinsen et al. 1994) .
Ionotropic glutamate receptors α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA) mediate fast excitatory synaptic transmission but also contribute to excitotoxic mechanisms that lead to cellular dysfunction and ultimately cell death. The sensorimotor cortex provides the major glutamatergic input to other cortical areas and to subcortical areas such as the dorsolateral striatum (Cospito and Kultas-Ilinsky 1981; Gubellini et al. 2004; McGeer et al. 1977; Reubi and Cuenod 1979) . Alterations in glutamatergic cortical cell function induce corticocortical and corticostriatal dysfunction, defective gating to the cortex and striatum and could contribute to HD symptoms such as motor impairment and learning deficits (Abbruzzese and Berardelli 2003; Dunnett et al. 2005; Sapp et al. 1999) .
In contrast to the human, most genetic mouse models of HD show behavioral and electrophysiological alterations in the absence of cell loss, suggesting that neuronal dysfunction is sufficient to produce HD symptoms (Levine et al. 2004 ). R6/2 mice are transgenic for exon 1 of the human HD gene and exhibit a progressive neurological phenotype characteristic of juvenile HD (Davies et al. 1997; Mangiarini et al. 1996) . In this model, cortical pyramidal neurons develop a late onset degeneration and display morphological alterations such as decreases in somatic size and number of spines, suggesting that inputs to the cortex are altered (Klapstein et al. 2001; Laforet et al. 2001; Turmaine et al. 2000) . In addition, striatal MSSNs in R6/2 mice display transient and progressive alterations in spontaneous excitatory synaptic activity that are likely to originate from changes in the corticostriatal pathway (Cepeda et al. 2003) . In the present study, we examined glutamate (AMPA and NMDA) receptor function and voltage-gated barium currents in pyramidal neurons of the sensorimotor cortex in the 3 R6/2 model of HD at different time points of the disease. We found that glutamate receptor function in cortical pyramidal neurons was altered early in R6/2 mice, and that changes in the cortex contrast from those occurring in striatal cells in R6/2 mice of the same age.
Methods

Groups and cells
Experiments were performed on R6/2 transgenic mice and their wild type (WT) littermate controls. Mice were obtained from our colony at UCLA. All experimental procedures were performed in accordance with the United States Public Health Service
Guide for Care and Use of Laboratory Animals and were approved by the Institutional
Animal Care and Use Committee at UCLA. Three age groups of R6/2 mice were studied: 21 days (before overt behavioral symptoms), 40 days (when the behavioral phenotype begins) and 80 days (fully symptomatic). Forty-six mice in the three age groups were used (Table I ). In the 21 day group, NMDA and AMPA currents were recorded from the same cells to reduce the number of animals and because we found in preliminary tests that exposure to either AMPA or NMDA did not alter average current amplitudes induced by the other agonist (Table I ). In the 40 and 80 day groups, we used different concentrations of agonists to determine the most effective concentration. As our ejection system did not have enough capacity to perform dose-response curves for two agonists on the same neurons, cells were tested separately for AMPA and NMDA in these groups. Only data from cells for which access resistance values were smaller than 20 MΩ were included.
Dissociated cell preparation
Mice were anesthetized with halothane, transcardially perfused with 10 ml cold sucrose solution containing (in mM): 250 sucrose, 11 glucose, 15 HEPES, 1 Na 2 HPO 4 , 
Drug application
Drugs were applied through an array of application capillaries positioned 500-600
μm from the cell using a pressure-driven fast perfusion system. Solution changes were performed by changing the position of the array with a DC drive system controlled by a SF-77B perfusion system (Warner Instruments, Hamden, CT) synchronized by pClamp.
Solution changes were complete within <100 ms. Agonists, antagonists and modulators were applied for 3 sec every 10 sec. Voltage-gated Ba 2+ currents were evaluated by measuring the Ba 2+ peak current evoked by step voltage commands (-80 to -10 mV, 1 sec). Responsiveness of cells to 100 μM AMPA in the absence or presence of 10 μM cyclothiazide (CTZ, inhibitor of AMPA receptor desensitization) were examined at a holding potential of -80 mV to increase the driving force. The non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 μM) was applied to confirm the specificity of AMPA-induced currents. Responsiveness of cells to 100 μM NMDA and their sensitivity to 50 μM Mg 2+ were examined at four different holding potentials: -70, -40, -20 and 0 mV. The NMDA receptor specific antagonist 2-amino-5-phosphonovalerate (APV, 50 μM) was applied to confirm the specificity of NMDAinduced currents. We paid special attention to AMPA application to avoid the variability introduced by a relatively slow application system to measure a fast peak. Before recording the traces, we positioned the application capillaries at an optimal distance to induce the maximal peak current and we applied four times more pressure than for NMDA currents.
Data analysis
In the text, values are presented as means ± SEMs. Data analyses were performed with Origin (Microcal Software, Northampton, MA) and pClamp software.
Electrophysiological membrane properties and AMPA and NMDA current characteristics were compared using a two-way analysis of variance (ANOVA) followed by Bonferroni ttests using SigmaStat software (SPSS Inc., Chicago, IL). We used two-way repeated 6 measures ANOVAs followed by Bonferroni t-tests to compare NMDA current characteristics among different holding voltages and AMPA current characteristics before and after CTZ application in WT and R6/2 cells. To measure the desensitization time constants, AMPA current decay rates were fit using a single exponential. We chose to fit between the peak and at 300 ms after the peak, because at 300 ms AMPA currents reached a steady-state. The Simple PCI image analysis system software (Compix Inc., Cranberry Township, PA) was used to measure cell somatic area to compare cell sizes statistically among groups using a two-way ANOVA followed by Bonferroni t-tests. Differences were considered statistically significant when p<0.05.
Results
Membrane properties, cell morphology and Ba 2+ currents
Only data (Table II) . There was no significant change in Cm in the 21 and 80 day R6/2 cells. Input resistance (Rm) was significantly higher in R6/2 cells in the 40 day group while there was no significant change in the 21 and 80 day groups. Somatic areas were similar in R6/2 and WT cells at 21 40 and 80 days. In the 21 and 40 day groups, there were no statistically significant differences in Ba 2+ currents and current densities between WT and R6/2. In contrast, in the 80 day group, Ba 2+ currents and current densities were significantly larger in R6/2 cells (Table II) .
AMPA currents
Different concentrations of AMPA (10, 100 and 1000 μM) were applied in 40 day WT (n = 12) and R6/2 (n = 10) cells to determine the concentration-response function.
10 μM AMPA induced a non-desensitizing current while 1000 μM AMPA induced a fast 7 desensitizing current that decreased to a steady-state plateau in WT and R6/2 cells.
The response to 100 μM AMPA varied between WT and R6/2 cells. Most WT cells responded with a fast peak that desensitized slowly to a steady-state. Those with a fast desensitizing peak usually showed smaller steady-state values. In contrast, most R6/2 cells responded with a fast desensitizing peak (Fig. 1B) . Peak current densities evoked by the three concentrations were significantly smaller in the R6/2 transgenic cells (Fig. 1B, C). We chose the non-saturating concentration of 100 μM AMPA for subsequent experiments. AMPA current block by CNQX (10 μM) was tested in the 40 and 80 day groups. CNQX blocked 80-90% of AMPA-induced currents in WT and R6/2 cells. There was no difference between percent blockade across genotypes (data not shown).
We measured the peak and the steady-state amplitudes of AMPA currents at 100
μM concentration in each age group (Fig. 2 ). R6/2 neurons displayed significantly smaller AMPA (peak and steady-state) current amplitudes and densities compared to WT cells at 40 days. At 21 days, AMPA (peak and steady-state) amplitudes and densities were not statistically different, although they tended to be smaller in R6/2 cells.
At 80 days, AMPA peak current amplitudes and densities, and steady-state current amplitudes and densities were similar between WT and R6/2 cells (Fig. 2) .
Desensitization rates (measured 300 ms after the peak) were significantly shorter in R6/2 compared to WT cells at 21 days [48.7 ± 3.5 ms (WT) vs 34.4 ± 4.3 (R6/2)] and at 40 days [40.5 ± 3.0 ms (WT) vs 29.4 ± 2.9 (R6/2); two-way ANOVA followed by Bonferroni t-tests, p < 0.05]. However, there were no statistically significant differences between WT and R6/2 cells at 80 days [(47.7 ± 4 .0 ms (WT) vs 40.7 ± 2.8 (R6/2)].
To determine if the differences in AMPA currents in WT and R6/2 cells could result from differential splicing of the subunits into flip and flop forms, we measured the mean steady-state to peak ratio for AMPA currents. The ratio was significantly smaller Co-application of 10 μM CTZ reduced the desensitization and potentiated AMPAinduced currents in all WT and R6/2 cells at each age. AMPA peak currents were 6-8 8 times larger when CTZ and AMPA were co-applied. Furthermore, currents did not exhibit the fast desensitizing peak component observed with AMPA alone (Fig. 3A) . At 21 and 40 days, the AMPA peak current amplitudes and densities induced in the presence of CTZ were significantly smaller in R6/2 compared to WT cells (Fig. 3B) .
Furthermore, two types of responses to CTZ were observed in WT and R6/2 cells.
While CTZ reduced the fast desensitization of the AMPA current, there was still a slow desensitization (Fig. 3A , right trace) in about 50% of the WT cells (43% at 21 days, 44%
at 40 days and 50% at 80 days). In the R6/2 group we also found a slow desensitization of AMPA currents in the presence of CTZ at all ages (89% at 21 days, 87% at 40 days and 50 % at 80 days) (Fig. 3C ). The differences in frequency between R6/2 and WT for the slow desensitizing component were statistically significant at 21 and 40 days (Chi square, p<0.001 at both ages). At 80 days there was no difference in the percentage of cells showing desensitizing currents in the presence of CTZ in WT and R6/2 cells.
We then classified WT and R6/2 cells in two groups, depending on the presence of the AMPA desensitizing component in the presence of CTZ (see Fig. 3A ), and found differences in current characteristics. Currents induced by AMPA alone were significantly larger if the subsequent CTZ response showed no desensitization. This was reflected by smaller AMPA peak current amplitudes and densities for currents with the desensitizing component at all ages (Fig. 4A) . Similarly, in WT and R6/2 cells, in all age groups, AMPA currents modulated by CTZ were significantly larger when the currents did not desensitize (Fig. 4B) .
NMDA currents
We initially tested increasing concentrations of NMDA on pyramidal neurons in the absence of Mg 2+ in cells from 40 day old mice. Application of NMDA (1-1000 μM, 3 sec duration, V hold = -70 mV) induced inward currents that increased in a concentrationdependent manner. At concentrations of 30 μM or higher, the NMDA response consisted of a fast peak, followed by a slowly desensitizing component (Fig. 5B) . EC 50
for WT cells at 40 days was 53.0 ± 4.6; (n = 11) and was not different from R6/2 cells (45.0 ± 3.8; n = 12). NMDA-induced peak current amplitudes and densities for each NMDA concentration were similar in WT and R6/2 cells (Fig. 5C ). 50 μM of the specific This suggests that a complex interplay of ligand-and voltage-gated channel alterations occurs throughout the evolution of the disease, leading to different symptoms. These changes are region and time specific, as they are different in the cerebral cortex and the striatum.
Decreased glutamate currents
Application of glutamate receptor agonists onto dissociated cells in the whole-cell patch clamp configuration allows the study of postsynaptic receptor function in isolation.
Thus, the decreases in AMPA and NMDA currents we observed are most likely due to altered receptor properties. However, it may be argued the removal of most of the dendrites could affect the experimental outcome. This is unlikely because the cells we selected had similar dendritic fields. A limitation of our application system is the reduced speed that could introduce variability depending on the perfusion rate. Despite the fact that we maximized AMPA application (see Methods), it is possible that we missed some of the fast AMPA peak, which could explain the relatively high variability in AMPA peak current amplitudes compared to NMDA. Nevertheless, we found significant differences in peak current, desensitization and steady-state to peak current ratios consistent with a different subunit composition. Moreover, we confirmed smaller AMPA currents using CTZ, a component that blocks AMPA peak desensitization.
The subunit composition of NMDA and AMPA receptors determines many of the properties of the currents. AMPA receptors are composed of four subunits (GluR1-4). et al. 1994, 1995) . In the present study, we found that more pyramidal neurons in the
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WT groups displayed non-desensitizing currents, consistent with previous studies describing the preferential expression of the flip form in cortical pyramidal neurons (Lambolez et al. 1996) . The differences observed in R6/2 transgenic cells seem to be due to a change in AMPA receptor flip/flop subunit composition, since more cells from the R6/2 transgenic group displayed: 1) desensitizing AMPA/CTZ currents, 2) smaller AMPA/CTZ currents 3) smaller AMPA currents with faster desensitization time constants and 4) smaller steady-state to peak current ratio. We also found that the amplitude of desensitizing AMPA/CTZ currents was smaller than the amplitude of nondesensitizing currents, which explains the overall decreased amplitude in AMPA currents observed in R6/2 cells. antagonists (Ali and Levine 2005; Cepeda et al. 2001; Li et al. 2003; Zeron et al. 2002) .
Smaller AMPA and NMDA currents could also be the consequence of fewer receptors present at the cellular surface. It has been demonstrated that cortical pyramidal neurons from R6/2 transgenic mice show decreases in somatic size, the extent of the dendritic field and the number of spines (Klapstein et al. 2001) . We observed that the capacitance was smaller in the transgenic neurons at 21 and 40 days, which could partially account for smaller glutamate currents. However, the differences in NMDA and AMPA currents remained when we computed current density, indicating that alterations were not due solely to differences in cell size. Instead, a decrease in the number of AMPA and NMDA receptors in R6/2 cells could explain smaller currents. In fact, in R6/2 mice and HD in general, polyglutamine expansion impairs the ability of htt to bind to the postsynaptic density 95 protein and other plasma membrane-associated proteins that help anchor NMDA and AMPA receptors to the membrane and more specifically to the synapse (Jarabek et al. 2004; Luthi-Carter et al. 2003; Sun et al. 2001 ).
At a more integrative level, the cerebral cortex is interconnected with basal ganglia structures, and a function of these structures is to modulate sensory cortical input (Schwarz et al. 1992) . A decrease in glutamate receptor function in the cortex could therefore result from early alterations in the striatum. Since cortex and striatum are so closely interconnected, alterations in the cortex could also have an impact on the striatum. In order to determine which structures htt alters first, it is necessary to study the disease at very early time points. New lines of conditional mice expressing the mutated htt in certain cell types will certainly help to clarify the sequence of events leading to pathology (Gu et al. 2005 ). 
Consequences of smaller cortical
Comparison with previous studies
The fact that pyramidal neurons from R6/2 transgenic mice display smaller An important point is that there is a regional specificity in NMDA receptor function in R6/2 mice. In contrast to cortical pyramidal cells, MSSNs from R6/2 mice display larger NMDA currents very early in development and at later stages (15, 21 and 40 days) and show more susceptibilty to excitotoxicity (Cepeda et al. 2001; Laforet et al. 2001; Levine et al. 1999; Starling et al. 2005) . Although synaptic activity is decreased, it is possible that extrasynaptic receptors are upregulated in the striatum since deafferentation of the striatum induces a long-term upregulation of glutamate receptors (Wullner et al. 1994) . . At 21 days the mean peak current density at -70 mV was significantly smaller in R6/2 versus WT cells. At 40 and 80 days there were no significant differences in mean peak current densities at any holding potential. * Statistical significance using a two-way ANOVA followed by Bonferroni t-tests, p<0.05. days, the percent block was similar in WT and R6/2 cells. At 40 days, it was significantly larger in R6/2 compared to WT cells at -70 and -40 mV. At 80 days, the increase was significant only at -70 mV. * Statistical significance using a two-way ANOVA followed by
